Session Details: KEYNOTE REUNION DEBATE, 1 YEAR ON: Post-COVID-19 in the new world Debating how COVID-19 will impact the way we outsource and conduct clinical trials in the future; a follow up from our 2021 session, what has changed? 29-11-2022, 4:30 pm PANEL DISCUSSION: Clinical trials in Asia (Korea, China, Taiwan, India, Singapore) ‘Unlocking efficient strategies to manage multiple countries’ regulations for global trials to increase productivity and achieve high quality results from all operation sites
